SEC Form 4 · accession 0001209191-15-024587
QUAKER CHEMICAL CORP · KWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph A Berquist
Officer — VP & Managing Director - NA
Period of report
Mar 6, 2015
Accepted (ET)
Mar 10, 2015 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000081362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2015 | M | 895 | $38.13 | A | 13,926 | D | |
| Common StockF1 | Mar 6, 2015 | S | 364 | $81.0633 | D | 13,562 | D | |
| Common Stock | Mar 6, 2015 | S | 531 | $82.00 | D | 13,031 | D | |
| Common Stock | Mar 6, 2015 | M | 710 | $58.26 | A | 13,741 | D | |
| Common StockF2 | Mar 6, 2015 | S | 710 | $80.8004 | D | 13,031 | D | |
| Common Stock | Mar 6, 2015 | M | 737 | $73.47 | A | 13,768 | D | |
| Common StockF3 | Mar 6, 2015 | S | 678 | $80.3781 | D | 13,090 | D | |
| Common StockF4 | Mar 6, 2015 | S | 59 | $81.0647 | D | 13,031 | D | |
| Common StockF5 | Mar 6, 2015 | F | 368 | $80.24 | D | 12,663 | D | |
| Common Stock | holding | — | — | — | 2,446 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $38.13 | Mar 6, 2015 | M | 895 | D | Mar 6, 2015 | Mar 6, 2019 | Common Stock | 895 | 0 | D |
| Employee Stock Option (right to buy)F7 | $58.26 | Mar 6, 2015 | M | 710 | D | Mar 5, 2015 | Mar 5, 2020 | Common Stock | 710 | 710 | D |
| Employee Stock Option (right to buy)F8 | $73.47 | Mar 6, 2015 | M | 737 | D | Feb 27, 2015 | Feb 27, 2021 | Common Stock | 737 | 1,472 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.75 to $81.1750 inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.36 to $81.1300 inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.01 to $80.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.02 to $81.09, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- F5Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on March 6, 2012 under the Company's Long-Term Performance Incentive Plan.
- F6The options for this grant vested in three annual installments: 896 shares on March 6, 2013; 896 shares on March 6, 2014; and 895 shares on March 6, 2015.
- F7The options for this grant vest in three annual installments: 710 shares on March 5, 2014; 710 shares on March 5, 2015; and 710 shares on March 6, 2016.
- F8The options for this grant vest in three annual installments: 737 options on February 27, 2015; 736 options on February 27, 2016; and 736 options on February 27, 2017.